Your browser doesn't support javascript.
loading
Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
Parbhudayal, R Y; Garra, A R; Götte, M J W; Michels, M; Pei, J; Harakalova, M; Asselbergs, F W; van Rossum, A C; van der Velden, J; Kuster, D W D.
Afiliação
  • Parbhudayal RY; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands; Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands; The Netherlands Heart Institute, Utrecht, the Netherla
  • Garra AR; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands.
  • Götte MJW; Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands.
  • Michels M; Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Pei J; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, the Netherlands; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, the Netherlands.
  • Harakalova M; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, the Netherlands.
  • Asselbergs FW; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, the Netherlands; Durrer Center for Cardiovascular Research, Netherlands Heart Institute, Utrecht, the Netherlands; Institute of Cardiovascular Science, University College London, London, United Kingdom; Farr In
  • van Rossum AC; Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands; The Netherlands Heart Institute, Utrecht, the Netherlands.
  • van der Velden J; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands; The Netherlands Heart Institute, Utrecht, the Netherlands.
  • Kuster DWD; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, the Netherlands. Electronic address: d.kuster@vumc.nl.
J Mol Cell Cardiol ; 123: 59-63, 2018 10.
Article em En | MEDLINE | ID: mdl-30170119
ABSTRACT

BACKGROUND:

Mutations in MYBPC3 are the most common cause of hypertrophic cardiomyopathy (HCM). These mutations produce dysfunctional protein that is quickly degraded and not incorporated in the myofilaments. Most patients are heterozygous and allelic expression differs between cells. We hypothesized that this would lead to cell-to-cell variation in cardiac myosin binding protein-C (cMyBP-C, encoded by MYBPC3 gene) protein levels.

METHODS:

Twelve HCM patients were included (six had no sarcomere mutations (HCMsmn) and served as the control group and six harbored mutations in the MYBPC3 gene (MYBPC3mut). Western blot and RNA sequencing analysis of cardiac tissue lysates were performed to detect overall cMyBP-C protein and mRNA levels. Cellular expression of cMyBP-C and α-actin was obtained by immunofluorescence staining. Quantification of cell-to-cell variation of cMyBP-C expression between cardiomyocytes was measured by determining the ratio of cMyBP-Cα-actin stained area of each cell.

RESULTS:

Protein and mRNA analysis revealed significantly reduced cMyBP-C levels in MYBPC3mut patients compared with HCMsmn patients (0.73 ±â€¯0.09 vs. 1.0 ±â€¯0.15, p < .05; 162.3 ±â€¯16.4 vs. 326.2 ±â€¯41.9 RPKM, p = .002), without any sign of truncated proteins. Immunofluorescence staining of individual cardiomyocytes in HCMsmn patients demonstrated homogenous and equal cMyBP-Cα-actin staining ratio. In contrast, MYBPC3mut patients demonstrated inhomogeneous staining patterns with a large intercellular variability per patient. Coefficient of variance for cMyBP-C/α-actin staining for each patient showed a significant difference between both groups (17.30 ±â€¯4.08 vs. 5.18 ±â€¯0.65% in MYBPC3mut vs. HCMsmn, p = .02).

CONCLUSION:

This is the first study to demonstrate intercellular variation of myofilament cMyBP-C protein expression within the myocardium from HCM patients with heterozygous MYBPC3 mutations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Proteínas de Transporte / Regulação da Expressão Gênica / Mutação / Miofibrilas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Mol Cell Cardiol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Proteínas de Transporte / Regulação da Expressão Gênica / Mutação / Miofibrilas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Mol Cell Cardiol Ano de publicação: 2018 Tipo de documento: Article